The Claim

In adults with newly diagnosed Graves' disease, the addition of 500 mg L-carnitine and 83 mcg selenium to methimazole reduces the median time to TRAb negativity from 13.6 months to 9.1 months, resulting in a 2.35-fold faster decline in pathogenic autoantibodies and a reduced risk of relapse and Graves' orbitopathy.

Source: Adding L-Carnitine and Selenium to Methimazole in Graves’ Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
69score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

In adults newly diagnosed with Graves' disease, adding 500 mg L-carnitine and 83 mcg selenium to methimazole shortens the time for harmful antibodies to become undetectable from 13.6 months to 9.1 months, leading to a 2.35-fold faster reduction in these antibodies and a lower rate of disease recurrence and eye complications.

See the scientific wording

In adults with newly diagnosed Graves' disease, adding 500 mg L-carnitine and 83 mcg selenium to methimazole reduces the median time to TRAb negativity from 13.6 months to 9.1 months, indicating a 2.35-fold faster decline in pathogenic autoantibodies, which may improve long-term prognosis by reducing the risk of relapse and Graves' orbitopathy.

Why this might work

Selenium reduces harmful oxidative stress in the thyroid and immune cells, which calms overactive immune responses and stops the production of antibodies that attack the thyroid. L-carnitine blocks thyroid hormones from entering cells, which reduces the overstimulation of metabolism and immune activity. Together, they cause the harmful antibodies to disappear faster, allowing the immune system to stop attacking the thyroid and return to normal function.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Adding L-Carnitine and Selenium to Methimazole in Graves’ Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life

    When people with Graves' disease took L-carnitine and selenium along with their regular medicine, their harmful antibodies disappeared about four months faster than those who took only the regular medicine. This might mean their disease is less likely to come back or hurt their eyes.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.